Skip to main content
Scroll Top
Menu
WHO WE ARE
ABOUT US
TEAM
MANAGEMENT TEAM
INDUSTRIAL ADVISORS
SCIENTIFIC COUNCIL
PARTNERS
R&D
INTRODUCTION
TECH
NEUROSTIMULATION
PHOTOBIOMODULATION
ALZHEIMER
CLINICAL TRIAL
PATHOPHYSIOLOGY
TECHNOLOGY
CONCUSSION
CLINICAL TRIAL
PATHOPHYSIOLOGY
TECHNOLOGY
SOLUTIONS
CLINICAL RESEARCH
PRECLINICAL RESEARCH
CONCUSSION
NEWS
ALL
PRESS ARTICLES
VIDEOS
EVENTS
SCIENTIFIC PUBLICATIONS
ALL
SCIENTIFIC ARTICLES
ORAL COMMUNICATIONS
POSTED COMMUNICATIONS
CONTACT
FAQ
Executive summary
Français
Menu
WHO WE ARE
ABOUT US
TEAM
MANAGEMENT TEAM
INDUSTRIAL ADVISORS
SCIENTIFIC COUNCIL
PARTNERS
R&D
INTRODUCTION
TECH
NEUROSTIMULATION
PHOTOBIOMODULATION
ALZHEIMER
CLINICAL TRIAL
PATHOPHYSIOLOGY
TECHNOLOGY
CONCUSSION
CLINICAL TRIAL
PATHOPHYSIOLOGY
TECHNOLOGY
SOLUTIONS
CLINICAL RESEARCH
PRECLINICAL RESEARCH
CONCUSSION
NEWS
ALL
PRESS ARTICLES
VIDEOS
EVENTS
SCIENTIFIC PUBLICATIONS
ALL
SCIENTIFIC ARTICLES
ORAL COMMUNICATIONS
POSTED COMMUNICATIONS
CONTACT
FAQ
Executive summary
Français
Home
Tag
Montpellier: Regenlife sheds light on the fight against Alzheimer’s disease
Alzheimer
28 May 2026
Montpellier: Regenlife sheds light on the fight against Alzheimer’s disease
A helmet and a belt to slow the progression of Alzheimer’s disease: an ingenious idea being tested at the Hospices Civils de Lyon
Alzheimer
28 May 2026
A helmet and a belt to slow the progression of Alzheimer’s disease: an ingenious idea being tested at the Hospices Civils de Lyon
Alzheimer’s disease: REGEnLIFE accelerates its Light4Life clinical trial with the opening of a new trial site at Lyon University Hospital, Hôpital des Charpennes
Alzheimer
1 April 2026
Alzheimer’s disease: REGEnLIFE accelerates its Light4Life clinical trial with the opening of a new trial site at Lyon University Hospital, Hôpital des Charpennes
IN THE SPOTLIGHT – REGEnLIFE: At the crossroads of medicine and physics – Pharmaceutiques Magazine No. 335 / March 2026
Alzheimer
Concussions
16 March 2026
IN THE SPOTLIGHT – REGEnLIFE: At the crossroads of medicine and physics – Pharmaceutiques Magazine No. 335 / March 2026
Slowing down neurodegeneration with light
Alzheimer
16 March 2026
Slowing down neurodegeneration with light
REGEnLIFE, the French NeuroTech DeepTech company shortlisted for the 2025 Prix Galien USA
Alzheimer
16 March 2026
REGEnLIFE, the French NeuroTech DeepTech company shortlisted for the 2025 Prix Galien USA
“Conceiving an innovation is one thing; bringing it to fruition is quite another.” Guillaume Blivet wants to transform the lives of patients with neurological disorders
Alzheimer
Depression
Multiple sclerosis
16 March 2026
“Conceiving an innovation is one thing; bringing it to fruition is quite another.” Guillaume Blivet wants to transform the lives of patients with neurological disorders
Can Light Heal the Brain? REGEnLIFE Explores Photobiomodulation for Alzheimer’s
Alzheimer
Depression
Multiple sclerosis
15 March 2026
Can Light Heal the Brain? REGEnLIFE Explores Photobiomodulation for Alzheimer’s
[Initiatives] Two new centers open in Paris for a clinical trial on Alzheimer’s disease
Alzheimer
15 March 2026
[Initiatives] Two new centers open in Paris for a clinical trial on Alzheimer’s disease
Alzheimer’s: REGEnLIFE opens two new centres in Paris for its clinical trial
Alzheimer
15 March 2026
Alzheimer’s: REGEnLIFE opens two new centres in Paris for its clinical trial
France TV – Health: innovations that will amaze you – December 3 2025
6 March 2026
France TV – Health: innovations that will amaze you – December 3 2025
France INTER highlights our Light4Life clinical trial for Alzheimer’s patients
6 March 2026
France INTER highlights our Light4Life clinical trial for Alzheimer’s patients
1
2
…
4
Next
Get a Quote
